Switch to:
More From Other Websites
Zogenix says former obesity drug reduced seizures in study May 27 2015
Zogenix says former obesity drug reduced seizures in study May 27 2015
Zogenix Announces New Efficacy Data From a Long-Term Study of Low-Dose Fenfluramine for Treatment of... May 27 2015
ZOGENIX, INC. Files SEC form 8-K, Other Events May 27 2015
8:31 am Zogenix announces new efficacy data from a long-term study of low-dose Fenfluramine for... May 27 2015
Zogenix Announces New Efficacy Data From a Long-Term Study of Low-Dose Fenfluramine for Treatment of... May 27 2015
ZOGENIX, INC. Financials May 20 2015
10-Q for Zogenix, Inc. May 13 2015
Zogenix reports 1Q loss May 11 2015
Zogenix reports 1Q loss May 11 2015
Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results May 11 2015
ZOGENIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 11 2015
Zogenix Provides Corporate Update and Reports First Quarter 2015 Financial Results May 11 2015
Q1 2015 Zogenix Inc Earnings Release - After Market Close May 11 2015
10-K for Zogenix, Inc. May 06 2015
Zogenix to Release First Quarter 2015 Financial Results and Host Conference Call & Webcast on May 11 May 04 2015
Zogenix to Release First Quarter 2015 Financial Results and Host Conference Call & Webcast on May 11 May 04 2015
ZOGENIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Apr 28 2015
Dr. Stephen Farr Appointed as CEO of Zogenix to Lead New Strategic Focus and Advance Late-Stage CNS... Apr 27 2015
ZOGENIX, INC. Files SEC form 8-K, Change in Directors or Principal Officers Apr 27 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK